Pemetrexed disodium hemipenta hydrate - 2.5(H2O)
CAS: 357166-30-4
Rif. 3D-FP71598
50mg | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
- N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate
- Pemetrexed disodium 2.5H2O
- 2-[4-[2-(4-Amino-2-oxo-3,5,7-triazabicyclo[4.3.0]nona-3,8,10-trien-9-yl)ethyl]benzoyl]aminopentanedioic acid disodium salt hydrate
- Pemetrexed Disodium hemipenta hydrate
- Pemetrexed disodium hemipentahydrate
Pemetrexed disodium hemipenta hydrate is a drug that is used in the treatment of cancer. It is an inhibitor of the enzyme dihydrofolate reductase, which prevents the synthesis of DNA and RNA. Pemetrexed disodium hemipenta hydrate is not toxic to normal cells and has minimal side effects. This drug has been shown to inhibit tumor growth in mouse models and human patients with lung cancer. Pemetrexed disodium hemipenta hydrate is administered intravenously as an injection solution for cancer treatment trials.